We recently reported claims that the DEA has granted unnamed private pharmaceutical companies license to grow cannabis for experimental purposes. Now, the Sacramento News & Review on Dec. 19 cites a report from the Union of Medical Marijuana Patients to the effect that the United States government holds a patent on the use of cannabinoids as "antioxidants and neuroprotectants"—specifically, the Department of Health & Human Services holds Patent #6630507, as documented at the US Patent & Trademark Office.
Recent comments
9 weeks 6 days ago
15 weeks 4 days ago
26 weeks 4 days ago
27 weeks 4 days ago
29 weeks 1 day ago
29 weeks 4 days ago
29 weeks 6 days ago
34 weeks 2 days ago
35 weeks 3 days ago
35 weeks 3 days ago